Core A: Administrative Core
Core A: Administrative Core
批准号:
10684102
负责人:
Jeffrey Wallace Tyner
金额:
$26.65万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-30 至 2027-08-31
关键词:
Acute Myelocytic LeukemiaAdministratorAgreementArchitectureBioinformaticsBiologyBiostatistics CoreBudgetsClinicalCollaborationsCommunicationCommunitiesComplexDataEnsureEnvironmentEvaluationEvolutionFosteringFundingGoalsGrantHemeIndividualIntellectual PropertyIntrinsic factorLaboratoriesLeadLeadershipNational Cancer InstituteOffice of Administrative ManagementOutcomePatientsPerformancePreparationProductivityProgress ReportsRecommendationReportingResearchResearch PersonnelResistanceResourcesScientific EvaluationScientistSpecimenSystemTechnologyTimeTranslational ResearchTravelWorkacquired drug resistancedata disseminationdata sharingexperienceinnovationleukemiameetingsnovel therapeutic interventionoperationpre-clinicalprogramstherapy resistanttimelinetumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT: Administrative Core
The overall goal of our leukemia focused ARTNet Research Center is to understand how the architecture of
resistance is governed by temporal extrinsic and intrinsic factors in order to identify novel therapeutic strategies
to stay ahead of tumor evolution and adaptation in patients with Acute Myeloid Leukemia (AML). To achieve this
goal, we have assembled an exceptional team of leukemia researchers that bridge basic/mechanistic and
preclinical/translational research who have worked extensively together for 15+ years studying AML biology. The
Administrative Core will provide leadership, scientific oversight, governance, integration, and administrative
support to the ARTNet Research Center to ensure effective operations, communication, internal and external
collaborations, compliance, and rigorous scientific evaluation of ARTNet Consortium funded projects. The
Administrative Core co-Leads, Dr. Jeffrey Tyner (Contact M-PD/PI) and Dr. Cristina Tognon, have been working
together for close to a decade, and they have also both worked closely for this entire time with Administrative
Core Biostatistics and Bioinformatics Lead and Overall M-PD/PI, Dr. Shannon McWeeney. They will be
supported by a highly experienced Research and Finance Administrator, Sarah Bowden. The specific aims of
the Administrative Core are to: 1) Provide overall administrative management by providing governance and
scientific integration of the Center and developing and implementing a staffing plan; 2) Create an environment
that fosters a focused and synergistic relationship between the Projects and the Cores; 3) Provide ARTNet
Research Center compliance oversight and evaluate scientific progress; and 4) Enable rapid dissemination of
data and resources. To achieve these aims, the Administrative Core will establish and implement ARTNet
Research Center governance, including establishing a Scientific Advisory Board (SAB) to help evaluate the
Center’s progress toward its aims and milestones; plan regular strategic interactions and meetings; develop
communication plans; ensure budget oversight and compliance; manage intellectual property issues; complete
annual progress reports; facilitate regular and timely communication; facilitate collaboration within the Center
and with external collaborations; and perform all other administrative duties required to support the ARTNet
Research Center and its successful participation in the Acquired Resistance to Therapy Network.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10038080
-
项目类别:
-
资助金额:$6.32万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Trajectory and Architecture of Tumor Intrinsic Drug Resistance in AML
-
批准号:10684105
-
项目类别:
-
资助金额:$30.41万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Administrative Core
-
批准号:10494402
-
项目类别:
-
资助金额:$9.33万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Trajectory and Architecture of Tumor Intrinsic Drug Resistance in AML
-
批准号:10517760
-
项目类别:
-
资助金额:$36.95万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Drug Combinations to Enhance Sensitivity and Circumvent Resistance
-
批准号:10249170
-
项目类别:
-
资助金额:$37.93万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Drug Combinations to Enhance Sensitivity and Circumvent Resistance
-
批准号:9985235
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Administrative Core
-
批准号:9985230
-
项目类别:
-
资助金额:$6.38万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Core A: Administrative Core
-
批准号:10517758
-
项目类别:
-
资助金额:$7.01万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Drug Combinations to Enhance Sensitivity and Circumvent Resistance
-
批准号:9444902
-
项目类别:
-
资助金额:$72.78万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Administrative Core
-
批准号:10249167
-
项目类别:
-
资助金额:$6.32万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Drug Combinations to Enhance Sensitivity and Circumvent Resistance
-
批准号:10038085
-
项目类别:
-
资助金额:$37.93万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
-
批准号:8997484
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2014
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
-
批准号:9213359
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2014
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
-
批准号:8670455
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2014
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
-
批准号:8828622
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2014
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
ROR1 as a Therapeutic Target in Acute Lymphoblastic Leukemia
-
批准号:8544411
-
项目类别:
-
资助金额:$23.36万
-
财政年份:2012
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
ROR1 as a Therapeutic Target in Acute Lymphoblastic Leukemia
-
批准号:8715697
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2012
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
ROR1 as a Therapeutic Target in Acute Lymphoblastic Leukemia
-
批准号:8526776
-
项目类别:
-
资助金额:$24.85万
-
财政年份:2012
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
ROR1 as a Therapeutic Target in Acute Lymphoblastic Leukemia
-
批准号:8126307
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2010
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
ROR1 as a Therapeutic Target in Acute Lymphoblastic Leukemia
-
批准号:7952615
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2010
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
海外基金